2/26
10:29 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/26
10:29 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/26
09:14 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/25
06:24 am
acad
ACADIA Pharmaceuticals (ACAD) was upgraded by Wolfe Research to "strong-buy".
Low
Report
ACADIA Pharmaceuticals (ACAD) was upgraded by Wolfe Research to "strong-buy".
2/25
06:24 am
acad
ACADIA Pharmaceuticals (ACAD) was upgraded by Wolfe Research to "strong-buy".
Low
Report
ACADIA Pharmaceuticals (ACAD) was upgraded by Wolfe Research to "strong-buy".
2/24
07:10 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/24
07:10 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/23
06:01 pm
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/23
06:01 pm
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Low
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/23
04:18 pm
acad
Acadia Pharmaceuticals initiated with an Outperform at Wolfe Research
Low
Report
Acadia Pharmaceuticals initiated with an Outperform at Wolfe Research
2/23
04:18 pm
acad
Acadia Pharmaceuticals initiated with an Outperform at Wolfe Research
Low
Report
Acadia Pharmaceuticals initiated with an Outperform at Wolfe Research
2/23
05:26 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/23
05:26 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/23
05:10 am
acad
Acadia Pharmaceuticals upgraded to Outperform from Neutral at Mizuho
Low
Report
Acadia Pharmaceuticals upgraded to Outperform from Neutral at Mizuho
2/23
05:10 am
acad
Acadia Pharmaceuticals upgraded to Outperform from Neutral at Mizuho
Low
Report
Acadia Pharmaceuticals upgraded to Outperform from Neutral at Mizuho
2/6
12:15 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/6
12:15 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/6
08:43 am
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "market perform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "market perform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
2/3
11:03 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/3
11:03 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
2/3
08:03 am
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $37.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $37.00 price target on the stock.
1/6
01:35 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
1/6
01:35 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
1/6
12:17 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
1/6
07:07 am
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at Citigroup Inc..